CHG.BK
Strong BuyFull HouseAI screen passChularat Hospital Public Company Limited · Healthcare · Thailand · $513M
THB 1.56 +2.0% · close 6 Oct · scored 7 Oct
Full House: Strong business, sensible price, market agrees. The rare full house.
Does StockRank work? Each month we publish how every decile did, whichever way it went. See the record →
Screen-pass. Chularat Hospital Public Company Limited: Q73/V67/M62, every leg clears the 50 floor and the 60 strong bar; corroborated by all three legs >= 60 (no filing signal required). Nothing adverse known: no net insider selling and no negative forward-EPS revision. A light-tier screen-pass, not a high-conviction pick.
The ranks quoted here are from the day it was written; today's Quality, Value and Momentum are the bars above.
ABOUT CHULARAT HOSPITAL PUBLIC COMPANY LIMITED
Read
Chularat Hospital Public Company Limited, together with its subsidiaries, operates clinics and hospitals in Thailand. The company also provides a comprehensive health screening center. In addition, it sells medicine and medical supplies.
FINANCIAL SUMMARY (THB)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 10.1B | 7.7B | 8.2B | 8.3B | -6.2% | 8.6B | 8.6B | 9.0B | 4.0% |
| EPS (THB) | 0.25 | 0.10 | 0.09 | 0.08 | -30.6% | 0.09 | 0.09 | 0.09 | 5.2% |
| Shares | 11.0B | 11.0B | 11.0B | 11.0B | 0.0% | 11.0B | — | — | — |
| Debt | 870.4M | 750.0M | 705.9M | 583.6M | -12.5% | 593.6M | — | — | — |
| Equity | 7.5B | 7.5B | 7.7B | 7.8B | 1.3% | — | — | — | — |
| Op CF | 2.6B | 2.1B | 1.7B | 1.7B | -14.1% | 1.5B | — | — | — |
| Inv CF | -958.3M | -1.4B | -549.9M | -668.4M | — | — | — | — | — |
| Fin CF | -2.5B | -1.3B | -870.6M | -923.9M | — | — | — | — | — |
Calmer than 68% of stocks we rank over the past year (32% a year).
How this is worked out
What it measures: day-to-day price moves over the past year, as a yearly figure, ranked against every stock we cover. Very calm under 20% a year, Calm 20 to 30%, Average 30 to 40%, Bumpy 40 to 55%, Very bumpy above that.
What we found: across about 13,500 stocks in 34 markets (2002 to 2025), past swings were a good guide to the next year's, and bumpier stocks fell further. How much further changed too much between eras to put a number on it.
Calm is not safe: a calm stock can still slide steadily.
Rules fixed before any data was fetched. Describes the chart, not a recommendation.
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of CHG.BK are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| CHG.BK | Chularat Hospital Public Company Limited(you) | $513M | 91 | Strong Buy |
| SKR.BK | Sikarin Public Company Limited | $468M | 86 | Strong Buy |
| PR9.BK | Praram 9 Hospital Public Company Limited | $453M | 84 | Strong Buy |
| BCH.BK | Bangkok Chain Hospital Public Company Limited | $842M | 81 | Strong Buy |
| VIBHA.BK | Vibhavadi Medical Center Public Company Limited | $544M | 67 | Buy |
| RJH.BK | Rajthanee Hospital Public Company Limited | $132M | 93 | Strong Buy |
| RAM.BK | Ramkhamhaeng Hospital Public Company Limited | $624M | 66 | Buy |
| VIH.BK | Srivichaivejvivat Public Company Limited | $163M | 98 | Strong Buy |
| TNH.BK | Thai Nakarin Hospital Public Company Limited | $153M | 83 | Strong Buy |
| EKH.BK | Ekachai Medical Care Public Company Limited | $123M | 86 | Strong Buy |
Peer medians: ROE 12.0% · P/E 14.4x · Gross margin 27.9%
Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.